Drug Type Autologous CAR-T |
Synonyms |
Target |
Mechanism BCMA inhibitors(B-cell maturation protein inhibitors), Immunologic cytotoxicity, T lymphocyte replacements |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Multiple Myeloma | Discovery | CN | 21 Dec 2020 |